drugset
drugset / Trial / NCT02511691

PET/MRI Imaging of Glutamate Release in the Brain

NCT02511691 ↗

Phase 2 Terminated 10 enrolled University of Zurich
NaSingle-groupOpen-labelDiagnostic

Summary

Based on PET (18-PSS232) and MRI, glutamate release after N-acetylcystein challenge will be monitored in human brains.

Timeline

Start
2015-07
Primary completion
2016-03-03
Completion
2016-03-03

Outcome

Outcome not reported

Stopped: “Enough data for a publication, decision of Sponsor-PI”

Drugs

EvaluationDrugModalityDoseRoute
Subject 18F-PSS232 Diagnostic / imaging agent — —

Indications

No indication recorded.